Blend: Ipamorelin CJC-1295 (No DAC) 20MG For Sale
Description
Blend: Ipamorelin CJC-1295 (No DAC) 20MG is a premium research peptide combination widely studied for its potential role in growth hormone research, endocrine signaling studies, and advanced peptide-based scientific exploration. This synergistic blend pairs two well-researched peptides—Ipamorelin and CJC-1295 (No DAC)—both of which are frequently investigated in laboratory settings for their interaction with growth hormone secretagogue pathways and pulsatile signaling mechanisms. This research-grade 20MG formulation is manufactured exclusively for laboratory and scientific research applications.
Ipamorelin is a selective growth hormone secretagogue receptor (GHS-R1a) agonist commonly studied for its ability to stimulate growth hormone release pathways without strongly affecting other endocrine hormones in research models. CJC-1295 (No DAC) is a growth hormone-releasing hormone (GHRH) analog designed for short-acting, pulsatile signaling research, making it a valuable compound for studies focused on natural secretion rhythms and hormonal feedback systems. When combined, these peptides are often researched for their complementary effects on growth hormone pulse dynamics and endocrine regulation models.
The Blend: Ipamorelin CJC-1295 (No DAC) 20MG provides researchers with a precisely measured formulation designed for accuracy, consistency, and controlled laboratory handling. Each vial is manufactured using advanced peptide synthesis techniques and strict quality control standards to ensure high purity, stability, and reliable performance in research environments. This combination format allows researchers to streamline experimental setups involving dual-peptide endocrine studies.
Within peptide research environments, this blend is frequently examined for its role in growth hormone axis signaling, pituitary response modeling, and hormonal feedback loop investigations. Scientific studies often focus on how GHRH analogs and ghrelin receptor agonists may interact within controlled biological systems to better understand pulsatile secretion behavior. Due to its relevance in endocrine and metabolic research, this blend has become widely utilized in advanced peptide science studies.
Researchers value the Ipamorelin and CJC-1295 (No DAC) combination for its potential to support structured research models involving growth hormone regulation, recovery-related biological processes, and cellular signaling pathways. Its dual-mechanism profile makes it particularly useful in experimental designs aiming to evaluate synergistic peptide interactions within controlled laboratory conditions.
The 20MG blend concentration offers flexibility for precise measurement and structured research applications requiring accurate peptide dosing within experimental protocols. Laboratories appreciate the consistency and compatibility of this formulation with a wide range of scientific research environments. Proper storage and handling procedures are recommended to maintain peptide integrity and ensure reproducible results.
Every batch of Blend: Ipamorelin CJC-1295 (No DAC) 20MG undergoes rigorous quality assurance testing to support laboratory-grade purity, accurate peptide identification, and dependable research performance. Controlled manufacturing environments and advanced synthesis processes ensure consistency across batches, making this blend suitable for professional scientific applications.
As peptide science continues to evolve, this combination remains an important tool in endocrine research, growth hormone signaling studies, and metabolic peptide investigations. Its increasing relevance in advanced laboratory research has made it a widely utilized formulation in modern peptide science focused on hormonal regulation and biological signaling pathways.
Blend: Ipamorelin CJC-1295 (No DAC) 20MG is intended strictly for scientific and laboratory research purposes only. It is not intended for human consumption, therapeutic use, or medical application. All peptide research should be conducted by qualified professionals following appropriate laboratory guidelines and safety standards.
Ipamorelin CJC-1295 Peptide Information
FORM |
Powder(lyophilized) |
|---|---|
CAS NUMBER |
Ipamorelin: 170851-70-4 MOD-GRF(1-29) CJC-1295 No DAC: 863288-34-0 |
OTHER NAMES |
Ipamorelin Acetate, IPAM, NNC-26-0161 MOD-GRF(1-29), CJC-1295 without DAC, modgrf |
WEIGHT |
10mg | 10mg |
SEQUENCE |
Ipamorelin: Aib-His-D-2-Nal-D-Phe-Lys-NH2 MOD-GRF(1-29) CJC-1295 No DAC: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg |
Molecular Weight |
Ipamorelin: 711.85296 g/mol MOD-GRF(1-29) CJC1295 No DAC: 33367.954 g/mol |
Terms |
Subject to our Terms and Conditions. This material is sold for laboratory research use only. Not for human consumption, animal, or medical use. |
Why isn’t there more information on Ipamorelin CJC 1295 No DAC?
Due to the legal landscape of peptides and research products, providing information that may imply anything beyond laboratory research use is a legal liability. We’re an expert biotechnology company that provides high quality peptides and products for purchase to advance scientific research in this field.

















Reviews
There are no reviews yet.